Signet Investment Advisory Group, Inc. Bristol Myers Squibb CO Transaction History
Signet Investment Advisory Group, Inc.
- $196 Million
- Q4 2024
A detailed history of Signet Investment Advisory Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Signet Investment Advisory Group, Inc. holds 8,261 shares of BMY stock, worth $508,134. This represents 0.24% of its overall portfolio holdings.
Number of Shares
8,261
Previous 8,072
2.34%
Holding current value
$508,134
Previous $417,000
11.99%
% of portfolio
0.24%
Previous 0.21%
Shares
21 transactions
Others Institutions Holding BMY
# of Institutions
2,762Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.7 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.76 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.91 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.85 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.71 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $131B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...